Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia
- 1 February 1987
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 144 (2) , 151-158
- https://doi.org/10.1176/ajp.144.2.151
Abstract
Using [11C]-deoxy-D-glucose and positron emission tomography (PET), the authors measured brain metabolism in 18 patients with chronic schizophrenia to assess which of the metabolic measures from two test conditions was more closely related to the patients'' differing clinical characteristics. The two conditions were resting and activation, and an eye tracking task was used. Patients with more negative symptoms showed lower global metabolic rates and more severe hypofrontality than did the patients with fewer negative symptoms. Differences among the patients were distinguished by the task: sicker patients failed to show a metabolic activation response. These findings suggest that cerebral metabolic patterns reflect clinical characteristics of schizophrenic patients.This publication has 13 references indexed in Scilit:
- Anteroposterior Gradients in Cerebral Glucose Use in Schizophrenia and Affective DisordersArchives of General Psychiatry, 1984
- Human brain glucose utilization and cognitive function in relation to ageAnnals of Neurology, 1984
- 15O POSITRON EMISSION TOMOGRAPHIC SCANNING IN PREDOMINANTLY NEVER-TREATED ACUTE SCHIZOPHRENIC PATIENTSThe Lancet, 1983
- Use of 2-Deoxy-D[1-11C]Glucose for the Determination of Local Cerebral Glucose Metabolism in Humans: Variation within and between SubjectsJournal of Cerebral Blood Flow & Metabolism, 1982
- Ventricular enlargement in schizophrenia: relationship to positive and negative symptomsAmerican Journal of Psychiatry, 1982
- Cerebral Glucography With Positron TomographyArchives of General Psychiatry, 1982
- Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical EffectsJournal of Computer Assisted Tomography, 1981
- Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophreniaPsychopharmacology, 1980
- DOPAMINE AND SCHIZOPHRENIAThe Lancet, 1976
- CEREBRAL BLOOD FLOW AND METABOLISM IN SCHIZOPHRENIAAmerican Journal of Psychiatry, 1948